State Street's passive 4.6% stake is a routine index-fund-level holding. Monitor for any future 13D conversion or material changes in position size, but no near-term activist pressure is expected.
VERA drugs
VERA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $30.03entry
- T+1 · 6d ago +1.50%α +0.18% · $30.48
- T+4 · todayOpen
- T+5 · in 5h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
State Street Corp disclosed a 4.6% passive stake in Vera Therapeutics as of September 30, 2026, via a new Schedule 13G. This follows a prior 13G filing by State Street in August 2026, indicating a slight reduction from the earlier filing. The filing confirms passive intent with no activist purpose.
Key Financial Metrics
Key Facts
- State Street Corp filed a Schedule 13G disclosing beneficial ownership of 3,301,893 shares of Vera Therapeutics common stock as of September 30, 2026.
- The stake represents 4.6% of shares outstanding.
- State Street certifies the shares were acquired and are held in the ordinary course of business, with no intent to change or influence control.
- This is a new 13G filing by State Street; a prior 13G by State Street was filed on August 7, 2026.
Financial Impact
Passive stake of 4.6% valued at approximately $101 million based on the $2.2B market cap.
Risk Factors
- No material risks identified from this passive filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000740 |
| Document: 0000093751-26-000740-index.html | 0000093751-26-000740 |
| Document: 0000093751-26-000740.txt | 0000093751-26-000740 |
Track record
25 reports on VERA
13 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +36.47% at T+20 after the Jun 2, 2026 report. 14 of 14 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $27.55 Now $26.97 −2.11% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $28.15 Now $26.97 −4.19% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $28.15 Now $26.97 −4.19% settles Nov 23
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $30.03 Now $26.97 −10.19% settles Nov 17
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Bullish 6/10 Entry $29.79 to $28.10 Now $26.97 −9.45% ▼ −5.66% −8.25% vs SPY
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $31.97 to $30.48 Now $26.97 −15.64% ▼ −4.66% −3.75% vs SPY
- Oct 22, 202625d ago Press Release Bullish 8/10 Entry $29.05 to $30.53 Now $26.97 −7.16% ▲ +5.09% +4.39% vs SPY
- Sep 15, 20268w ago 8-K Bullish 8/10 Entry $33.67 to $34.00 Now $26.97 −19.90% ▲ +0.98% +0.16% vs SPY
- Aug 10, 202614w ago 8-K Neutral 5/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers